Advertisement

Topics

Xpovio combo bags FDA approval for refractory multiple myeloma

09:43 EDT 5 Jul 2019 | PharmaTimes

The application was also granted Fast Track designation, and Xpovio received Orphan Drug designation.

Original Article: Xpovio combo bags FDA approval for refractory multiple myeloma

NEXT ARTICLE

More From BioPortfolio on "Xpovio combo bags FDA approval for refractory multiple myeloma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...